Announcements

Kristina Kury, M.D., Pulmonology Receives Caring for People Hummingbird Award

Posted on Nov 3, 2020 in Announcements | 0 comments

Dr. Kury is the epitome of a good physician; she is kind, caring, calm and professional. Dr. Kury is respected by everyone who works with her. She treats everyone around her with respect and takes time to listen to what they have to say. She also shares critical feedback with poise and without judgement.

As a member of the healthcare team, I am proud to be working side by side with her. Her practice is based on kindness, intellectual understanding of best practices and logical reasoning. She is well respected because she knows how to command respect whether it’s during a critical care meeting discussion or during rounds or at the bedside, talking to patients. Dr. Kury talks to her patients with compassion and explains the disease processes and therapies in a way they can understand. She is inclusive in care planning and soliciting best practices from other members of the healthcare team. She openly engages and patiently educates staff about clinical practice to improve patient care.

Dr. Kury encourages active participation of the health care team. She actively listens to them and makes them feel comfortable to voice out their ideas and opinions. Dr. Kury always makes us an equally important part of the team; a true hummingbird, the symbolism of healers and bringers of love, good luck and joy. It’s always a pleasure to work with you.


Submitted by: Michael Chui, RRT Respiratory Care Services, Clinical Educator/Coordinator of RCS

Alta Bates Summit Celebrates National Pharmacy Week (Oct. 18 -24) Thank You to Our Summit Inpatient Pharmacy Team!

Posted on Nov 3, 2020 in Announcements | 0 comments

Guidance on Beta-Lactam Allergy in Prescribing Antibiotics

Posted on Oct 1, 2020 in Announcements | 0 comments

Intra Operative Radiation Therapy (IORT)

Posted on Oct 1, 2020 in Announcements | 0 comments

October is Breast Cancer Awareness Month.  This is a scary time to be a breast cancer patient due to the ongoing COVID-19 pandemic.  Many women have the option to keep their breast when they have breast cancer.  The cure rate for early stage breast cancer is the same whether the woman keeps her breast or has a mastectomy.  Most women rather keep their breast but then they usually have to undergo weeks of daily radiation.  Some women are forgoing this important part of their breast cancer treatment or choosing a mastectomy instead since they do not want to risk coming to a medical clinic every day for weeks.

Since 2011, ABSMC has been offering Intra Operative Radiation Therapy (IORT) for early stage breast cancer.  We have treated more than 350 patients with excellent results and published our data.  

We are very excited to share with you newly published long term results of the TARGIT-A trial in the British Medical Journal, 8/19/2020.  Once again the trial demonstrates that risk adapted IMMEDIATE single dose TARGIT-IORT radiation during lumpectomy is non-inferior to whole breast external beam radiation therapy (EBRT).  TARGIT-IORT has comparable long term efficacy for cancer control and lower non-breast cancer mortality.  At five year complete follow-up, the number of local recurrences was only 2.11% for TARGIT-IORT.

Women with early breast cancer were eligible if they were:
1)  aged 45 years or older, 
2)  had a diagnosis of a unifocal invasive ductal carcinoma, and 
3)  suitable for wide local excision with a cancer that was ≤3.5 cm in size on imaging. 

With long term follow-up (median 8.6 years, maximum 18.9 years), no statistically significant difference was found between immediate TARGIT-IORT and EBRT for the following outcomes: 

local recurrence-free survival (P=0.28), 
invasive local recurrence-free survival (P=0.70), 
mastectomy-free survival (P=0.74), 
distant disease free survival (P=0.30), 
overall survival (P=0.13), and 
breast cancer mortality (P=0.54). 

Mortality from other causes was significantly lower (P=0.005) in the TARGIT-IORT arm.

Benefits of TARGIT-IORT during lumpectomy for early stage invasive ductal breast cancer:

less travel, thus less cost,
less pain, 
better quality of life, 
cosmetically superior
fewer non-breast cancer deaths
less risky during the CV pandemic since most patients do not need to come in every day for weeks for external radiation
and IORT bridges the health care disparity gap for women of color.

TARGIT-IORT should be offered when planning breast cancer surgery, especially in these CV-19 pandemic times.  The patient gets all her radiation during her lumpectomy with less risk.

Respectfully,

Valery Uhl, MD
Radiation Oncology, IORT Specialist at ABSMC
President, TARGIT Collaborative Group (TCG)

Sutter Community Connect

Posted on Oct 1, 2020 in Announcements | 0 comments

Empiric Treatment of Enterococcus Infections

Posted on Sep 1, 2020 in Announcements | 0 comments